NARI (Inari Medical Corp) Total Debt to Capital

Inari Medical, Inc. (NARI) leads the physical venous clot retrieval segment with ClotTriever, which eliminates the need for pharmacological lysis and the associated risks of complications. This daily price chart reflects a dependence on the debt-to-equity ratio at 0.07, while demand for efficient systems among vascular surgeons continues to grow. The brand enjoys unconditional recognition from physicians for developing safe, minimally invasive life-saving techniques.

The analyst assesses the credit quality of Inari Medical, Inc. (NARI) through the total liabilities-to-equity ratio to determine the business's degree of dependence on borrowed funds. By analyzing the liability structure—specifically total debt to equity—the investor evaluates the balance between bankruptcy risk and profitability, which is particularly critical given the capital-intensive robotization of CNC lines used to manufacture thrombosis therapy equipment.